The Citizens Life Sciences Conference 2026 March 11, 2026 10:45 AM EDTCompany ParticipantsHelen Torley - President, ...

From the Department of Bizarre Anomalies: Microsoft has suppressed an unexplained anomaly on its network that was routing traffic destined to example.com—a domain reserved for testing purposes—to a ...

MRCP is a type of MRI scan used to look at organs like the pancreas, gallbladder, and liver. MRCP is less invasive than ERCP and does not use radiation. You will need to remove any metal objects ...

Using sertraline with amphetamines like Adderall can increase the risk of serotonin syndrome. Taking sertraline with other antidepressants may raise serotonin levels too much. Sertraline and blood ...

The updated indications state that if TNF blockers are clinically inadvisable, patients may still be administered Rinvoq if they have previously received at least 1 approved systemic therapy. The Food ...

As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose ...

Consumer advocacy organization Public Citizen is sounding the alarm about potential risks for birth defects associated with modafinil (Provigil) and armodafinil (Nuvigil), two stimulants commonly ...

Comparative effectiveness of mental health interventions on anxiety, depression and quality of life among cancer patients: A systematic review and network meta-analysis. Mapping policy effects: The ...

People with disabilities and chronic illnesses may find it more difficult to eat healthy, control their weight, and remain active, as a result of physical limitations, food desserts, a lack of ...

The US Food and Drug Administration (FDA) approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with both type 2 diabetes ...

Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed noninferiority ...